CYTARABINE vs DEPOCYT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 11, 2026·How we rate

Attribute	CYTARABINE	DEPOCYT
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	CYTARABINE	CYTARABINE
Manufacturer	Rising	Pacira Pharms Inc
Dosage forms	Injectable	Injectable, Liposomal
Drug class	Nucleoside Metabolic Inhibitor	Nucleoside Metabolic Inhibitor
Boxed warning	None	None
Treats	Leukemia, Lymphoma, Meningeal Neoplasms	Leukemia, Lymphoma, Meningeal Neoplasms

cytarabine depocyt

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

CYTARABINE

Manufacturer

Rising

Pacira Pharms Inc

Dosage forms

Injectable

Injectable, Liposomal

Drug class

Nucleoside Metabolic Inhibitor

Boxed warning

None

Treats

Leukemia, Lymphoma, Meningeal Neoplasms

Frequently asked questions

Which is better-rated, Cytarabine or Depocyt?

Cytarabine and Depocyt are tied at 3.6 out of 5 by our independent rating.

What is the difference between Cytarabine and Depocyt?

Both Cytarabine and Depocyt share the active ingredient Cytarabine.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.